Advertisement

Topics

New Data At EAN Show Genentech???s Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures Of Disease Progression In Relapsing And Primary Progressive Multiple Sclerosis

20:00 EDT 22 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: New Data At EAN Show Genentech???s Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures Of Disease Progression In Relapsing And Primary Progressive Multiple Sclerosis

NEXT ARTICLE

More From BioPortfolio on "New Data At EAN Show Genentech???s Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures Of Disease Progression In Relapsing And Primary Progressive Multiple Sclerosis"

Advertisement
Quick Search
Advertisement
Advertisement